ARTV Long Call Strategy

ARTV (Artiva Biotherapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including autoimmune diseases like lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, systemic lupus erythematosus, and specific anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes such as granulomatosis with polyangiitis/microscopic polyangiitis, in addition to B-cell non-Hodgkin lymphoma. The company's pipeline also includes AB-201, an allogeneic anti-human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell candidate, and AB-205, another allogeneic anti-CD5 CAR-NK cell candidate. Established in 2019, Artiva Biotherapeutics is headquartered in San Diego, California.

ARTV (Artiva Biotherapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $563.7M, a beta of 2.18 versus the broader market, a 52-week range of 2.22-14.53, average daily share volume of 527K, a public-listing history dating back to 2024, approximately 106 full-time employees. These structural characteristics shape how ARTV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.18 indicates ARTV has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long call on ARTV?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

ARTV snapshot

As of August 14, 2026, spot at $11.54, ATM IV 154.20%, expected move 44.21%. The long call on ARTV below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this long call structure on ARTV specifically: IV rank is unavailable in the current snapshot, so regime-based timing for ARTV is inferred from ATM IV at 154.20% alone, with a market-implied 1-standard-deviation move of approximately 44.21% (roughly $5.10 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ARTV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ARTV should anchor to the underlying notional of $11.54 per share and to the trader's directional view on ARTV stock.

ARTV long call setup

The ARTV long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ARTV at $11.54 on that close, the first option leg uses a $11.54 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ARTV chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ARTV shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$11.54N/A

ARTV long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ARTV long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ARTV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on ARTV

Long calls on ARTV express a bullish thesis with defined risk; traders use them ahead of ARTV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ARTV thesis for this long call

The market-implied 1-standard-deviation range for ARTV extends from approximately $6.44 on the downside to $16.64 on the upside. A ARTV long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. As a Healthcare name, ARTV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ARTV-specific events.

ARTV long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ARTV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ARTV alongside the broader basket even when ARTV-specific fundamentals are unchanged. Long-premium structures like a long call on ARTV are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ARTV chain quotes before placing a trade.

Frequently asked questions

What is a long call on ARTV?
A long call on ARTV is the long call strategy applied to ARTV (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ARTV stock at $11.54 on the most recent close, the strikes shown on this page are snapped to the nearest listed ARTV chain strike and the premiums come straight from that session's bid/ask midpoint.
How are ARTV long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ARTV long call priced from the end-of-day chain at a 30-day expiry (ATM IV 154.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ARTV long call?
The breakeven for the ARTV long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ARTV market-implied 1-standard-deviation expected move in the same options snapshot is approximately 44.21%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ARTV?
Long calls on ARTV express a bullish thesis with defined risk; traders use them ahead of ARTV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ARTV implied volatility affect this long call?
Current ARTV ATM IV is 154.20%; IV rank context is unavailable in the current snapshot.

Related ARTV analysis